Upgrade to SI Premium - Free Trial

Viridian Therapeutic (VRDN) PT Lowered to $29 at Wolfe Research

March 31, 2026 5:34 AM
Wolfe Research analyst Andy Chen lowered the price target on Viridian Therapeutic (NASDAQ: VRDN) to $29.00 (from $37.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change